Table 4.
Selected Commercially Available Biomarkers for Lung Cancer in the United States
| Name | Assay/Methods | Assay Measurement/Variables Measured | Biomarker Source |
Company |
|---|---|---|---|---|
| Nodify XL2 | MRM-MS | Two proteins | Blood | Biodesix |
| Nodify CDT | ELISA | Seven autoantibodies | Blood | Biodesix |
| Percepta Genomic Sequencing Classifier | RNA sequencing | Multigene biomarker score | Bronchial epithelial brushing | Veracyte |
| Percepta Nasal Swab | RNA sequencing | Multigene biomarker score | Nasal epithelial brush | Veracyte |
| LCP CNN | Convolutional neural network | Radiomic signature | CT scan image | Optellum |
| REVEAL | MagArray | Protein panel | Blood | MagArray |
ELISA = enzyme-linked immunosorbent assay; LCP CNN = Lung Cancer Predictor Convolutional Neural Network; MRM-MS = multiple reaction monitoring mass spectrometry.